Indeed Snapshot

Track Atara Biotherapeutics reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 29th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 29th, 2022 11:28AM Aug 29th, 2022 11:28AM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 28th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 28th, 2022 04:27AM Aug 28th, 2022 04:27AM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 27th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 27th, 2022 03:47AM Aug 27th, 2022 03:47AM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 25th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 25th, 2022 08:27AM Aug 25th, 2022 08:27AM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 23rd, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 23rd, 2022 10:20AM Aug 23rd, 2022 10:20AM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 21st, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 21st, 2022 12:03PM Aug 21st, 2022 12:03PM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 20th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 20th, 2022 01:40PM Aug 20th, 2022 01:40PM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 19th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 19th, 2022 12:04PM Aug 19th, 2022 12:04PM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 18th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 18th, 2022 03:47AM Aug 18th, 2022 03:47AM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:atra https://www.indeed.com/cmp/atara-biotherapeutics Aug 17th, 2022 12:00AM Open Atara Biotherapeutics, Inc. Pharmaceutical & Biotechnology Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients. RRv1_5M_25M 611 Gateway Blvd, Suite 900 South San Francisco, CA 94080 Pascal Touchon 4.20 5.00 5.00 3.80 4.20 4.00 4.00 4.20 Aug 17th, 2022 09:26AM Aug 17th, 2022 09:26AM Atara Biotherapeutics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.